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Modeling
Macromolecules
Since 1953, when James
Watson and Francis Crick
presented their double helix
model of DNA, the field of
structural biology has exploded.
New technologies have led to rapid break-
throughs in understanding the form and
function of a wide range of macromole-
cules.Indeed, most studies of life at the
molecular level are now considered incom-
plete without three-dimensional structures
to guide further research.
Structural biologists today use tech-
nologies such as nuclear magnetic reso-
nance (NMR) spectroscopy, X-ray diffrac-
tion crystallography, electron microscopy,
and computer modeling to discover and
define the form of macromolecules. Used
together, these technologies often provide a
more complete picture of biological phe-
nomena than anysingle technique.
Researchers at the NIEHS have empha-
sized computer modeling and NMR. The
institute was one of the first in the nation
to purchase silicon graphics workstations
that are now considered essential to model-
ing and visually displaying molecules.
Today, using far more advanced systems,
the NIEHS maintains a computer model-
ing group led by mathematical statistician
Tom Darden that provides institute scien-
tists with computational approaches to
complex research questions. Several other
groups at the NIEHS also use computer
modeling in their research.
Bodies in Motion
Computer modeling offers distinctive
capabilities for deciphering results ofother
structural modeling techniques. Crystal-
lography, for example, provides high-reso-
lution snapshots ofmolecular structures in
the solid state. However, molecules in solu-
tion are in constant motion, and a more
complete picture requires a knowledge of
their molecular dynamics. Quantum chem-
ical calculations and various experimental
techniques enable researchers to describe
Tom Darden
the force fields that determine how
atoms interact with each other.
With this information, scientists
can use Newton's equations of
motion to study the dynamics ofthe
molecules. Because of the enormous
number of equations that must be solved
to simulate the motion ofa macromolecule
for even a billionth of a second, this can
only be done byhigh-speed computers.
Not only is the computational speed
offered by computers essential to under-
standing molecular form and function, so
too is graphical representation. Computer
graphics provide highly detailed informa-
tion about the arrangement ofmolecules in
space the only way humans can readily
comprehend it-visually.
In the typical representation, called a
wireframe, lines depict bonds between
atoms with each endpoint representing an
atom. These lines can be colored based on
atom type for easy identification. Because a
macromolecule may consist of more than
3,000 atoms, the ability to isolate and
enlarge details is important. With a single
click of the computer mouse, researchers
can magnify a small portion of a molecule
or view just the backbone structure.
Another command allows the researcher to
instantly measure the distance between
atoms. The structure can even be rotated
to observe how the atoms are arranged in
space. "The important thing about a com-
puter representation is that you can ask a
lot of questions that are not answerable
experimentally," says Darden, such as
"What's the relationship between two
atoms over time? Do they ever come
together?"
Computer Viruses
Understanding molecular dynamics is espe-
cially crucial in drug design. In their search
for the discovery ofsubstrates or inhibitors
that will bind to a key enzyme, researchers
must know the precise shape of an
enzyme's binding site and the dynamics of
the enzyme and drug. Computer modeling
offers a technique for characterizing sub-
strate-enzyme binding that can assist
researchers in identifying and synthesizing
clinically effective compounds. Likewise,
researchers seeking to understand the
effects of environmental toxicants must
identify the cellular receptors with which
the compounds interact.
Research geneticist Thomas Kunkel
heads aproject that seeks to understand the
fidelity of DNA replication, particularly as
it relates to the HIV-1 virus that causes
AIDS. HIV-1 escapes an individual's
immune system and resists drugs such as
AZT by rapidly mutating. Designing a
drug to suppress the virus depends on
understandingexactlyhow it mutates.
In 1988, Kunkel demonstrated that
reverse transcriptase (RT), the enzyme that
HIV-1 uses to replicate the genome,
exhibits a high rate ofmutations that result
from slippage of the template with respect
to the primer strand of DNA. Researchers
then set out to understand what parts of
the enzyme were responsible for this phe-
nomenon. Kunkel's team chose a region of
the RT protein and began making a series
of mutant RT proteins, replacing various
amino acids and analyzing their effect on
DNA replication. The team identified sev-
eral residues that lead to slippage of the
DNA strands, but because they lacked
high-resolution structural data, they were
not able to rationalize how this occurred.
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In 1993, researchers at Rutgers Uni-
versitysuccessfiullyproduced an X-ray crys-
tallography structure of the HIV RT
bound to DNA. Although this was a major
breakthrough, it did not answer all the
questions. Kunkel has since turned to the
NIEHS's computer modelers to take this
low resolution information and build a
predictive model ofthe RT to suggest fur-
ther areas of experimentation. "The crys-
tallographic information basically provided
me with a bunch of isolated points in
space," says Darden. "Using a computer, I
hunted through the database of known
proteins to find fragments to fit these
points, and ended up with a model ofwhat
the structure might looklike."
According to Kunkel, the model sug-
gested changes that could be made in the
region ofinterest that will help researchers
understand precisely how the enzyme
binds its substrates. "With such under-
standing," Kunkel says, "there is a better
chance ofbeing able to design more effec-
tive drugs."
Making Sense of Metabolism
Computer modeling is also aiding
Masahiko Negishi, head ofthe pharmaco-
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genetics section of the Laboratory of Re-
productive and Developmental Toxi-
cology, in his study of P450s, a family of
proteins that plays a key role in metabo-
lism. P450s exhibit remarkable substrate
and product diversity. Two P450s may
differ by less than 10 amino acids out of
500, but this subtle difference may signifi-
cantly affect an individual's ability to
metabolize various drugs and chemicals.
Specificity of P450 activity can be altered
by a single amino acid substitution at a
key position. Based on such differences,
one person may be able to take 10 times
more ofa drug than another individual, or
the same dose ofa drug may cure one per-
son's symptoms but cause adverse side
effects in another. "If, for a given individ-
ual, we can pinpoint amino acid muta-
tions at particular points, we might be
able to predict their reaction to certain
drugs or chemicals and warn them away
from those that may cause them trouble,"
says Negishi.
To identify which amino acids are crit-
ical and at what times, researchers must
understand the structure of the P450.
Bacterial P450 is easy to crystallize, so its
structure can be easily determined.
However, mammalian P450 has so far
been resistant to crystallization. Its struc-
ture can only be inferred through comput-
er modeling. This is where Darden's team
comes in.
Proteins with similar sequences of
amino acids usually adopt similar orienta-
tions. Therefore, Darden gathered the
structural information known about the
bacterial P450 and information produced
by Negishi's team through site-directed
mutagenesis and enzyme analysis ofmam-
malian P450. Using sequence homology,
Darden was able to compute which amino
acids in the bacterial enzyme correspond
to the mammalian amino acids, resulting
in a proposed structure for the mam-
malian protein. Negishi is currently exper-
imenting with binding various substrates
,, to the modeled mammalian P450 to pre-
dict how a particular mutation affects the
a, activity ofthe enzyme.
Ca "There are two benefits I get from the
3 modeling," Negishi says. "I can get some
hypothesis as to why the mutations we see
> in the mammalian enzyme affect the sub-
strate specificity. And knowing why this
might be so, I can do further research. We
can go back to test the hypothesis that, for
example, the size of a particular amino
acid is crucial."
Genes on Screen
Computer modelers are using a similar
process with Roger Wiseman, director of
the Laboratory of Molecular Carcino-
genesis, in his search to understand the
workings of the BRCA1 gene. BRCA1
plays a key role in hereditary breast and
ovarian cancers. The gene appears to func-
tion as a tumor suppressor, but a mutation
affecting a relatively small number of
amino acids at the amino terminus of the
protein appears to decrease the gene's abil-
ity to regulate cell growth and to increase
an individual's chance of developing can-
cer. Wiseman has called upon NIEHS
computer modelers to create a three-
dimensional model of this section of the
BRCA1 protein to predict how it folds
and to determine which residues are on
the outside, interacting with other pro-
teins and DNA.
Using the sequence of amino acids for
BRCA1 and the sequence ofa related her-
pes virus protein for which the structure is
known, computer modeler Rachelle
Bienstock ran a series ofhomology studies
to come up with a model. "From this
model, I suggested some residues in the
protein that might bind to the DNA, and
I suggested some experiments that could
be done to mutate the protein to see if it
changes the binding affinity," says
Bienstock. "The more we learn about the
pathway the gene takes in mutating, the
more we have a chance to intervene."
Drug Design
Computer modeling is also helping to
unravel the secrets ofopioid peptides used
in the treatment of pain. The medicinal
use of these peptides, particularly those
derived from frog skin secretions, dates
back to ancient Assyria and Babylonia.
The indigenous peoples of the Amazon
Basin still use poisonous frog skin secre-
tions to coat the tips of their blow-gun
darts and in shamanistic rites. Scientists
believe these unique peptides might have
potential applications as therapeutic and
clinical compounds in the management of
chronic and acute pain and in the treat-
ment ofnarcotic addiction, alcohol depen-
dency, and suppression of the immune
response during transplant surgery.
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Over the past six years, Lawrence
Lazarus, head of the peptide neurochem-
istry section, has directed a project at the
NIEHS that involves synthesizing and ana-
lyzing deltorphin and dermorphin analogs
that are hundreds of times more potent
that the endogenous mammalian opioid
peptides (see EHP vol. 102, no.8, pp.
648-654). The ultimate goal ofthe project
is to design new and more potent opioid
agonists and antagonists that are clinically
applicable. Sharon Bryant, a chemist in the
group, uses molecular modeling to deter-
mine structural motifs of opioid peptides
to predict structure-activity relationships.
"Computer modeling helps us to visualize
possible orientations ofamino acids in the
_ molecule," Bryant says. "It also helps us to
understand the intermolecular dynamics.
Knowing the orientation of the structure
E in three-dimensional space would enhance
our efforts to design agonists and antago-
nists." Lazarus and his team have devel-
,, oped a number of dual-affinity agonists
and ultraselective opioid antagonists which
are currently being tested for their applica-
tion to human health.
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